Amwell® Announces Results for First Quarter 2025
Amwell (NYSE: AMWL), a provider of SaaS-based technology-enabled healthcare platforms, has announced its financial results for the first quarter ending March 31, 2025. The company will host a conference call on May 1, 2025, at 5 p.m. ET to discuss these results. The earnings report can be accessed through Amwell's investor relations website, and the conference call will be available via live audio webcast, with a replay accessible afterward on the investor relations site.
Amwell (NYSE: AMWL), fornitore di piattaforme sanitarie tecnologiche basate su SaaS, ha comunicato i risultati finanziari del primo trimestre chiuso al 31 marzo 2025. L'azienda terrà una conference call il 1° maggio 2025 alle 17:00 ET per discutere i risultati. Il rapporto sugli utili è disponibile sul sito delle relazioni con gli investitori di Amwell, e la conference call sarà trasmessa in diretta audio via webcast, con una replica accessibile successivamente sempre sul sito delle relazioni con gli investitori.
Amwell (NYSE: AMWL), proveedor de plataformas de salud habilitadas por tecnología basadas en SaaS, ha anunciado sus resultados financieros para el primer trimestre finalizado el 31 de marzo de 2025. La compañía realizará una llamada de conferencia el 1 de mayo de 2025 a las 5 p.m. ET para discutir estos resultados. El informe de ganancias está disponible en el sitio web de relaciones con inversionistas de Amwell, y la llamada de conferencia estará disponible a través de una transmisión de audio en vivo, con una repetición accesible posteriormente en el sitio de relaciones con inversionistas.
Amwell (NYSE: AMWL)는 SaaS 기반 기술 지원 헬스케어 플랫폼 제공업체로서 2025년 3월 31일 종료된 1분기 재무 결과를 발표했습니다. 회사는 2025년 5월 1일 오후 5시(동부 시간)에 이 결과를 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 실적 보고서는 Amwell 투자자 관계 웹사이트에서 확인할 수 있으며, 컨퍼런스 콜은 라이브 오디오 웨비캐스트로 제공되며 이후 투자자 관계 사이트에서 다시 듣기가 가능합니다.
Amwell (NYSE : AMWL), fournisseur de plateformes de santé technologiques basées sur SaaS, a annoncé ses résultats financiers pour le premier trimestre clos le 31 mars 2025. La société organisera une conférence téléphonique le 1er mai 2025 à 17h00 ET pour discuter de ces résultats. Le rapport sur les bénéfices est accessible via le site des relations investisseurs d'Amwell, et la conférence téléphonique sera disponible en webcast audio en direct, avec une rediffusion accessible par la suite sur le site des relations investisseurs.
Amwell (NYSE: AMWL), ein Anbieter von SaaS-basierten technologiegestützten Gesundheitsplattformen, hat seine Finanzergebnisse für das erste Quartal zum 31. März 2025 bekannt gegeben. Das Unternehmen wird am 1. Mai 2025 um 17:00 Uhr ET eine Telefonkonferenz abhalten, um diese Ergebnisse zu besprechen. Der Gewinnbericht ist über die Investor-Relations-Website von Amwell zugänglich, und die Telefonkonferenz wird per Live-Audio-Webcast übertragen, mit einer anschließenden Wiederholung auf der Investor-Relations-Seite.
- None.
- None.
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell’s investor relations website at investors.amwell.com to view the first quarter 2025 earnings report.
The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
Angela Vogen
Press@amwell.com
Investors:
Sue Dooley
sue.dooley@amwell.com
FAQ
When will Amwell (AMWL) report its Q1 2025 earnings?
How can investors access Amwell's Q1 2025 earnings call?
Where can I find Amwell's Q1 2025 earnings report?
What period does Amwell's Q1 2025 earnings report cover?
